2Murray J, Lopez AD. Global pattern of cause of death and burden of diseases in 1990, with projections to 2020 investing in health research and development report of the adhoc committee on health research relation to future intervention options. Geneva WHO, 1996.
3Ibrahim M, Rizk H, Appl LJ, et al. Hypertension prevallence, awanagement and control: in egypt, results from the egyptian national hypertension project(NHP). NHP Investigative Team[J]. Hypertension, 1995, 26: 886-890.
4Arroyo P, Fernandez V, Loria A, et al. Hypertension in urban Mexico: the 1992-1993 national survey of chronic diseases[J]. J Human Hypertens, 1999,13:671-675.
5The joint national committee on detection, evaluation, and treatment of high blood pressure. The fifth report of the joint national committee on detection evaluation, and trealrnent of high blood pressure JNC V[J]. Arch Intern Med, 1993,153-154.
6Burt VL, Whelton P, Roccella FJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991[J]. Hypertens, 1995,25: 305-313.
7Rihacek I, Soucek M, Kara T, et al. Primary pulmonary hypertension aspects of diagnosis and therapy[J]. Vnitr Lek,2003,49:482-489.
8Mar J, Rodriguez-Artalejo F. Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance[J]? J Hypertens,2001,19:149-155.
